Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer

NCT06186700 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT06186700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06186700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer
Lead sponsor
Mansoura University
Phase
Phase 2
Overall status
Completed
Start date
December 25, 2023
Completion date
December 1, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, breast cancer patients, doxorubicin, neoadjuvant therapy, taxane-induced peripheral neuropathy